The project stemmed from the growing evidence of the impact of lineage-specific transcription factors (including INSM1, YAP1, POU2F3, MYCL, and NEUROD1) in stratifying SCLC into different molecular subgroups. This evidence concerns the gene MYCL and small cell lung carcinoma.